Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.
about
Understanding natural herpes simplex virus immunity to inform next-generation vaccine designDevelopment of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceDevelopment of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeThe challenge of developing a herpes simplex virus 2 vaccine.Dendritic cells and vaccine design for sexually-transmitted diseases.A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infectionImmunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.Self-assembled or mixed peptide amphiphile micelles from Herpes simplex virus glycoproteins as potential immunomodulatory treatmentEvaluation of recombinant adenovirus vaccines based on glycoprotein D and truncated UL25 against herpes simplex virus type 2 in mice.Efficient production of recombinant glycoprotein D of herpes simplex virus type 2 in Pichia pastoris and its protective efficacy against viral challenge in mice.The expression of IL-2 and IL-4 in CD4(+) T cells from mouse lymph nodes and spleen during HSV-1-induced facial palsy.
P2860
Q26741484-C05CBB2C-9B26-4D55-81E7-4C6857B2D061Q35076638-48B3A26C-5C9E-461C-AB52-AA66B208513EQ35202180-42C8D38F-3D82-4135-8AE9-738519B76B0FQ35871689-7B5DB600-7199-4B12-8039-ACF91EA04D26Q36671106-73D5AFF1-05E0-4509-8010-264D2A738A1FQ36681262-EC1DB249-FAB8-4FFB-AF67-20EAB7B864B5Q37118262-B79E057B-5235-4BDE-B21E-48B379D5A3DCQ37127506-B05D48E9-0193-46AF-AC8C-0774E6334FE6Q37963480-A991CDEF-3654-41B5-A08D-A44EDBC32C45Q39565993-421D976E-752A-40CF-9107-A1F3CF636795Q40257387-5CF89844-EDB9-4DA7-87AE-484C579A3767Q40443062-4971DBB1-D561-4B78-9DD6-CD9A7C1AB000Q42252792-958EEE74-9764-4F67-AF8F-A23BFEC5A8F3
P2860
Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immunodominant epitopes in her ...... d HSV-2 seropositive subjects.
@ast
Immunodominant epitopes in her ...... d HSV-2 seropositive subjects.
@en
type
label
Immunodominant epitopes in her ...... d HSV-2 seropositive subjects.
@ast
Immunodominant epitopes in her ...... d HSV-2 seropositive subjects.
@en
prefLabel
Immunodominant epitopes in her ...... d HSV-2 seropositive subjects.
@ast
Immunodominant epitopes in her ...... d HSV-2 seropositive subjects.
@en
P2093
P2860
P1476
Immunodominant epitopes in her ...... d HSV-2 seropositive subjects.
@en
P2093
Anthony L Cunningham
Heather Dunckley
Janette Taylor
John Sidney
Karen Byth-Wilson
Katerina Lagios
Martine Denis
Neil Bodsworth
Rajiv Khanna
P2860
P304
P356
10.4049/JIMMUNOL.181.9.6604
P407
P577
2008-11-01T00:00:00Z